Loading…
Lobbying Spend
—
Filings
31
Firms Hired
1
Active Period
2018–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Orange Book Transparency Act of 2020
2020 · first_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2020 · first_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1520
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2374
Preserve Access to Affordable Generics and Biosimilars Act
2020 · first_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2375
Prescription Pricing for the People Act of 2019
2020 · first_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2376
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Client expense: — · Firm income: $45,000
Matched citations: H.R. 965
Orange Book Transparency Act of 2020
2019 · fourth_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2019 · fourth_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1520
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2374
Preserve Access to Affordable Generics and Biosimilars Act
2019 · fourth_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2375
Prescription Pricing for the People Act of 2019
2019 · fourth_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2376
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 965
Orange Book Transparency Act of 2020
2019 · third_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2019 · third_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1520
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2374
Preserve Access to Affordable Generics and Biosimilars Act
2019 · third_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2375
Prescription Pricing for the People Act of 2019
2019 · third_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2376
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 965
Orange Book Transparency Act of 2020
2019 · second_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1503
Further Extension of Continuing Appropriations Act, 2021
2019 · second_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 1520
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2374
Preserve Access to Affordable Generics and Biosimilars Act
2019 · second_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2375
Prescription Pricing for the People Act of 2019
2019 · second_quarter · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 2376
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Client expense: — · Firm income: $45,000
Matched citations: H.R. 965
Source: Senate LDA